Skip to main content
Clinical Trials/CTRI/2024/05/067136
CTRI/2024/05/067136
Not yet recruiting
Phase 3

TO evaluate the changes in quality of life of patients suffering from Chronic Diseases by Homoeopathic Medicine with and without considering past history an open label randomized control trial - NI

ational Institute of Homoeopathy0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: R69- Illness, unspecified
Sponsor
ational Institute of Homoeopathy
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
ational Institute of Homoeopathy

Eligibility Criteria

Inclusion Criteria

  • Patient of any gender and 18\-65 years of age.
  • Patient suffering from chronic disease having marked past history.
  • Patients of any religion and any socio\-economical background.
  • Patient able to read/understand Hindi and/or English and/or Bengali.
  • Patients willing to take part in the study and who give written consent.

Exclusion Criteria

  • Patients suffering from any congenital deformity.
  • Patient suffering from any type of autoimmune disorders and/ or systemic diseases (like hypertension, diabetes mellitus, cardiovascular diseases etc.) who are undergoing any treatment or on regular medication.
  • Patient suffering from any type of invasive malignant disease/ neoplasia.
  • Patient is having prolonged psychiatric illness in his or her past history.
  • Pregnant, postpartum and lactating women.
  • Patient suffering from any immunocompromised state.
  • Patients with habit of substance abuse and / or dependence.
  • Vulnerable populations like unwilling to take part, too sick for consultation, not giving consent to join the study, mentally disabled people.
  • Already been in homoeopathic treatment for any chronic illness for the last 3 months.
  • Simultaneous participation in any other clinical trial.

Outcomes

Primary Outcomes

Not specified

Similar Trials